Ubs Asset Management Americas Inc Global Blood Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $5.36 Million - $11.3 Million	-165,292 Reduced 40.32%	244,631 $16.7 Million
Q2 2022 Aug 12, 2022	BUY	$22.3 - $37.39 $7.44 Million - $12.5 Million	333,449 Added 436.03%	409,923 $13.1 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $34,642 - $48,010	1,349 Added 1.8%	76,474 $2.65 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $21,759 - $31,888	854 Added 1.15%	75,125 $1.91 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $571,653 - $764,669	-17,611 Reduced 19.17%	74,271 $2.6 Million
Q1 2021 May 14, 2021	BUY	$38.94 - $50.85 $92,287 - $120,514	2,370 Added 2.65%	91,882 $3.74 Million
Q4 2020 Mar 01, 2021	BUY	$37.65 - $63.77 $575,781 - $975,234	15,293 Added 20.61%	89,512 $3.88 Million
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $103,304 - $145,851	1,958 Added 2.71%	74,219 $4.09 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $13,741 - $23,073	282 Added 0.39%	72,261 $4.56 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $242,226 - $506,283	5,806 Added 8.77%	71,979 $3.68 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $220,639 - $395,220	4,828 Added 7.87%	66,173 $5.26 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $540,073 - $689,650	11,909 Added 24.09%	61,345 $2.98 Million
Q2 2019 Aug 15, 2019	BUY	$52.6 - $63.29 $595,063 - $715,999	11,313 Added 29.67%	49,436 $0
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $61,464 - $82,198	-1,537 Reduced 3.88%	38,123 $0
Q4 2018 Feb 13, 2019	BUY	$31.54 - $46.67 $252,761 - $374,013	8,014 Added 25.32%	39,660 $1.63 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $26,790 - $36,025	705 Added 2.28%	31,646 $0
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $40,596 - $52,607	1,049 Added 3.51%	30,941 $0
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $232,887 - $387,557	5,881 Added 24.49%	29,892 $0
Q4 2017 Feb 09, 2018	BUY	$29.7 - $45.7 $490,376 - $754,552	16,511 Added 220.15%	24,011 $0
Q3 2017 Nov 13, 2017	BUY	$25.1 - $31.05 $188,250 - $232,875	7,500	7,500 $0

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account